This review highlights three key clinical applications of GH secretagogues: hexarelin's cardioprotective effects in rats, GHRP-based growth promotion in GH-deficient children, and GHRP-2/TRH for reversing ICU muscle wasting.
3 organ systemsGH secretagogues demonstrate therapeutic potential across cardiovascular, skeletal growth, and metabolic/catabolic domains
What the researchers found
GH secretagogues demonstrate three distinct clinical applications: hexarelin cardioprotection, pediatric growth promotion, and ICU catabolic reversal with GHRP-2/TRH combination.
Why it matters
The breadth of GH secretagogue applications — from protecting hearts to growing children to saving ICU patients — demonstrates these peptides have diverse therapeutic value that extends far beyond their original GH-releasing indication.
How the study worked
Mini-review synthesizing key findings from animal (cardiac) and human (pediatric growth, critical illness) studies of GH secretagogue effects.
What this study cannot tell us
Brief review with limited depth on each application. Cardiac data from animals only. Pediatric and ICU applications based on small studies.
How to read the evidence
Moderate evidence from a review summarizing key findings from the most clinically relevant GH secretagogue studies.
When this study was published
Published in 1999. These three application areas have all been further developed, with varying degrees of clinical advancement.
The bigger picture
GH secretagogues are evolving from single-indication drugs (GH deficiency) to multi-system therapeutic agents. Each application targets a different organ system through a common mechanism — GHS receptor activation.
Questions still open
- Which GH secretagogue application will reach clinical approval first?
- Can a single GH secretagogue address multiple indications?
- Are the non-GH effects important for each clinical application?
Common questions
What can GH peptides treat besides GH deficiency?
Are these uses proven in humans?
Read the original research
Clinical and experimental effects of growth hormone secretagogues on various organ systems.
Hormone research, 51 Suppl 3, 16-20
Citation
Svensson, J A; Bengtsson, B. (1999). Clinical and experimental effects of growth hormone secretagogues on various organ systems.. Hormone research, 51 Suppl 3, 16-20.